Reply to Jakovac; Severity of COVID-19 infection in patients with phenylketonuria: is vitamin D status protective?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Meta-analysis of bone mineral density in adults with phenylketonuria.Orphanet journal of rare diseases · 2024
   Pooled it
2. Metabolic signature of COVID-19 progression: potential prognostic markers for severity and outcome.Metabolomics : Official journal of the Metabolomic Society · 2025
   Article
3. Phenylalanine and COVID-19: Tracking disease severity markers.International immunopharmacology · 2021
   Article
4. Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?American journal of physiology. Endocrinology and metabolism · 2020
   Article

Corrections and comments

• Commented on by
  Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?2020
• Comment on
  COVID-19 and vitamin D-Is there a link and an opportunity for intervention?2020

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as